The payer will still hold a minority stake in the company but will use the acquired funds to repurchase stock, according to the Nov. 3 announcement.
“With more than 25 years of experience in home-based care, USMM has outperformed in numerous value-based care initiatives and consistently delivered lower costs, better health outcomes, and higher patient satisfaction ratings,” said Sarah London, vice chair of Centene’s board of directors. “We are confident this transaction will best position USMM to expand its reach and impact while helping Centene to deliver on our value creation plan.”
Rubicon Founders, Valtruis, Oak HC/FT and HLM Venture Partners will be purchasing Centene’s stake after federal clearance and other closing conditions.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.